2023 annual financial data
Cardiff Oncology 2023 Revenue growth
Direct answer
Revenue growth was 26.42%.
Operating income was -45,412,000 USD and net income was -41,441,000 USD.
Operating cash flow was -30,887,000 USD.
Get free Cardiff Oncology email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 488,000 USD
- Operating income
- -45,412,000 USD
- Net income
- -41,441,000 USD
- Operating cash flow
- -30,887,000 USD